ARCHIVES

NCI Plans $30 Million In Patient-Oriented Chemoprevention research In Next 5 Years

This article is from The Cancer Letter archive.

Vol. 22 No. 47 | December 6, 1996

Download PDF Visit The Full Archive

Related Articles

Letter: A Modest Proposal To Abolish FDA

January 26, 1996

Proof of principle needed before launching “big science” program, advisors say.

March 11, 2005

Trials Approved by NCI CTEP For the Month of April

April 27, 2012

340B Drug Discount Program: HRSA Defends Orphan Drug Rule

June 20, 2014

Cancer survivors number 9.8 million in U.S., CDC says.

June 25, 2004

In Brief: AMY ABERNETHY Was Named Chair of a New CancerLinQ Advisory Committee Within the Institute for Quality, An Affiliate Of The American Society of Clinical Oncology.

November 22, 2013